Latest Amgen Items
  • NY AG settles with pharmacy over kickback claims

    A national long-term care pharmacy accused of accepting kickbacks from a drug manufacturer has agreed to a settlement of more than $4 million, with New York getting a share of the money.

  • Justices appear divided on class-action lawsuits

    The Supreme Court appeared divided Monday in two cases in which businesses are trying to make it harder for customers or investors to band together to sue them.

  • George Rathmann, first CEO of Amgen, dies in Ca.

    George Rathmann, who as founding CEO took Amgen Inc. from a small company with an unclear mission in a strange new field and helped turn it into the world's largest biotech drugmaker, has died at age 84.

  • FDA questions Amgen drug for prostate cancer

    Scientists for the Food and Drug Administration say that an Amgen drug slowed the spread of cancer to the bone in men with hard-to-treat prostate cancer, though the drug did not extend life and carried significant side effects.

  • Amgen bone drug OK'd for use in cancer patients

    Biotech drugmaker Amgen says federal health regulators approved its bone-strengthening drug for preventing fractures and skeletal-problems in patients with advanced cancer.

  • Biotech drugmaker Amgen's 3Q profit falls 11 pct

    Biotechnology company Amgen Inc. on Monday posted an 11 percent drop in third-quarter profit on flat sales and higher operating costs, although the drugmaker still beat expectations.

  • Payment system hit for dialysis

    The Medicare payment system for dialysis drugs encourages doctors to prescribe aggressive dosing levels that can lead to heart attacks and strokes in kidney patients, lawmakers said yesterday.

Happening Now